Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) is a term used to describe disorders that involve chronic inflammation of the digestive tract, leading to symptoms like abdominal pain, diarrhea, and weight loss.
We are evaluating how well healthy adults tolerate single and multiple doses of the new medication O3R-5671-PRO. This study aims to ensure the safety of the drug for future use.
Health conditions and diseases that the clinical trial is designed to study and treat.
Inflammatory Bowel Disease (IBD) is a term used to describe disorders that involve chronic inflammation of the digestive tract, leading to symptoms like abdominal pain, diarrhea, and weight loss.
Psoriasis is a chronic autoimmune condition that causes rapid skin cell growth, leading to thick, red, scaly patches on the skin, often accompanied by itching and discomfort.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.